All In Biotech

Drug Trial Radar · NCT06411288

Global Study of Del-desiran for the Treatment of DM1

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Global Study to Evaluate the Efficacy and Safety of Intravenous AOC 1001 for the Treatment of Myotonic Dystrophy Type 1

Last checked: Nov 20, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 159 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

159

Actual

Start

May 30, 2024

Primary completion

Jul 23, 2026

Study completion Jul 29, 2026

Sponsor

Lead sponsor
Avidity Biosciences, Inc.Industry
Sponsor type
Industry
First posted
May 13, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 16 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Global Study to Evaluate the Efficacy and Safety of Intravenous Delpacibart Etedesiran (abbreviated del-desiran, formerly AOC 1001) for the Treatment of Myotonic Dystrophy Type 1

Conditions

  • DM1
  • Myotonic Dystrophy
  • Myotonic Dystrophy 1
  • Myotonia
  • Myotonic Dystrophy Type 1 (DM1)
  • Dystrophy Myotonic
  • Myotonic Disorders
  • Steinert Disease
  • Steinert
  • Myotonic Muscular Dystrophy

Interventions

  • AOC 1001 (del-desiran)Drug

    Del-desiran will be administered by intravenous (IV) infusion.

  • PlaceboDrug

    Placebo will be administered by intravenous (IV) infusion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Hand functionTime frame: Through Week 54

Locations

34 sites in 10 countries. Site status is shown where the registry gives one.

  • Stanford University

    Stanford, California

  • University of Colorado

    Denver, Colorado

  • University of Florida

    Gainesville, Florida

  • University Research Center of South Florida

    Tampa, Florida

  • Indiana University (IU)

    Indianapolis, Indiana

  • Kansas University Medical Center

    Kansas City, Kansas

  • Kennedy Krieger Institute

    Baltimore, Maryland

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • University of Minnesota

    Minneapolis, Minnesota

  • University of Rochester Medical Center

    Rochester, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Wake Forest

    Winston-Salem, North Carolina

  • University of Cincinnati Gardner Neuroscience Institute

    Cincinnati, Ohio

  • Ohio State University

    Columbus, Ohio

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Houston Methodist Neurological Institute

    Houston, Texas

  • Virginia Commonwealth University

    Richmond, Virginia

  • University of Washington

    Seattle, Washington

  • The Ottawa Hospital

    Ottawa, Ontario, Canada

  • Montreal Neurological Institute

    Montreal, Quebec, Canada

  • Aarhus University Hospital

    Aarhus N, Denmark

  • Rigshospitalet

    Copenhagen, Denmark

  • AP-HP Hopital Pitie-Salpetriere

    Paris, France

  • Klinikum der Ludwig-Maximilians-Universitaet Muenchen

    Munich, Germany

  • Fondazione Serena Onlus - Centro Clinico NeMO Milano

    Milan, Italy

  • National Hospital Organization Osaka Toneyama Medical Center

    Osaka, Japan

  • Osaka University Hospital

    Osaka, Japan

  • National Center of Neurology and Psychiatry

    Tokyo, Japan

  • Aomori Hospital

    Aomori, Aomori, Japan

  • Maastricht University Medical Center

    Maastricht, Netherlands

  • Stichting Radboud Universitair Medisch Centrum

    Nijmegen, Netherlands

  • Hospital Universitario Donostia

    Donostia / San Sebastian, Spain

  • University College London Hospital

    London, United Kingdom

  • St. Georges University Hospitals NHS Foundation Trust

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.